NERV vs DBVT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 04, 2026

NERV

54.7
AI Score
VS
NERV Wins

DBVT

42.1
AI Score

Investment Advisor Scores

NERV

55score
Recommendation
HOLD

DBVT

42score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NERV DBVT Winner
Net Income -8.80M -98.00M NERV
Operating Income -7.51M -98.50M NERV
ROE -19.4% -61.1% NERV
ROA -7.9% -43.9% NERV
Total Assets 111.83M 223.20M DBVT
Cash 80.14M 174.90M DBVT
Current Ratio 24.32 3.72 NERV

Relative Price Performance (Last 90 Days)

NERV 1M: -26.8% · 3M: -33.3% DBVT 1M: -22.5% · 3M: -32.4%

Current Technical Phase

NERV

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.0%), weak momentum, RSI 33

RSI (14): 33.4 · Price: $3.28

DBVT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.5%), weak momentum, RSI 31

RSI (14): 30.8 · Price: $10.55

Fundamentals Snapshot

Metric NERV DBVT
Market Cap — —
Forward P/E -7.8 -24.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -0.5%
Gross Margin — 1.0%
Operating Margin 0.0% -72.3%
EPS -34.83 -3.35
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NERV is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.